High-resolution MS for structural characterization of protein therapeutics: Advances and future directions

Bioanalysis

Volumn 5, Issue 10, 2013, Pages 1299-1313

  Wei, Hui ^a   Tymiak, Adrienne A ^a   Chen, Guodong ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARAGINYLTHREONYLLEUCYLTYROSYLLEUCYLGLUTAMYLMETHIONYLASPARAGINYLSERYLLEUCYLARGININE; ASPARTIC ACID; BETA 2 MICROGLOBULIN; BETA1A INTERFERON; DEUTERIUM; HYDROGEN; ISOASPARTIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYPEPTIDE; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; AMINO ACID SEQUENCE; CHEMICAL ANALYZER; DEAMINATION; DEUTERIUM HYDROGEN EXCHANGE; DRUG DETERMINATION; HYDROXYL RADICAL FOOTPRINTING; MASS SPECTROMETRY; ORBITRAP MASS ANALYZER; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY;

DEUTERIUM EXCHANGE MEASUREMENT; HUMANS; MASS SPECTROMETRY; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEINS;

EID: 84878492683     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.80     Document Type: Review

References (162)

1. Leader B, Baca QJ, Golan DE. Protein therapeutics. a summary and pharmacological classifcation. Nature Rev. 7(1), 21-39 (2008).
2. Aggarwal S. What's fueling the biotech engine-2008. Nature Biotechnol. 27(11), 987-993 (2009).
3. Chen G, Pramanik BN. Application of LC-MS to proteomics studies: current status and future prospects. Drug Discov. Today 14(9-10), 465-471 (2009).
4. Mo J, Tymiak AA, Chen G. Structural mass spectrometry in biologics discovery. advances and future trends. Drug Discov. Today 17(23-24), 1323-1330 (2012).
5. Mimura Y, Nakamura K, Tanaka T, Fujimoto M. Evidence of intra-and extracellular modifcations of monoclonal IgG polypeptide chains generating charge heterogeneity. Electrophoresis 19(5), 767-775 (1998).
6. Kroon DJ, Baldwin-Ferro A, Lalan P. Identifcation of sites of degradation in a therapeutic monoclonal antibody by peptide mapping. Pharma. Res. 9(11), 1386-1393 (1992).
7. Pramanik BN, Lee MS, Chen G (Eds). Characterization of impurities and degradants using mass spectrometry. Wiley 1-462 (2011).
8. Gross ML, Chen G, Pramanik BN. Protein and Peptide Mass Spectrometry in Drug Discovery. Wiley, NJ, USA 1-464 (2012).
9. Finehout EJ, Lee KH. An introduction to mass spectrometry applications in biological research. Biochem. Mol. Biol. Educ. 32(2), 93-100 (2004).
10. Hoofnagle AN, Resing KA, Ahn NG. Protein ana lysis by hydrogen exchange mass spectrometry. Annu. Rev. Biophys. Biomol. Struct. 32, 1-25 (2003).
11. Karas M, Bachmann D, Bahr U, Hillenkamp F. Matrix-assisted ultraviolet laser desorption of non-volatile compounds. Int. J. Mass Spectrom. Ion Processes 78, 53-68 (1987).
12. Chowdhury SK, Katta V, Chait BT. Electrospray ionization mass spectrometric peptide mapping. a rapid, sensitive technique for protein structure ana lysis. Biochem. Biophys. Res. Commun. 167(2), 686-692 (1990).
13. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 246(4926), 64-71 (1989).
14. Marshall AG, Hendrickson CL. High-resolution mass spectrometers. Annu. Rev. Anal. Chem. (Palo Alto Calif.) 1, 579-599 (2008).
15. Tito MA, Miller J, Walker N et al. Probing molecular interactions in intact antibody. antigen complexes, an electrospray time-of-fight mass spectrometry approach. Biophys. J. 81(6), 3503-3509 (2001).
16. Abzalimov RR, Bobst CE, Salinas PA, Savickas P, Thomas JJ, Kaltashov IA. Studies of pH-dependent self-association of a recombinant form of arylsulfatase A with electrospray ionization mass spectrometry and size-exclusion chromatography. Anal. Chem. 85(3), 1591-1596 (2013).
17. Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S. Advances and challenges in analytical characterization of biotechnology products. Mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol. Adv. 30(1), 210-222 (2012).
18. Berkowitz SA, Engen JR, Mazzeo JR, Jones GB. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nature Rev. 11(7), 527-540 (2012).
19. Chernushevich IV, Loboda AV, Thomson BA. An introduction to quadrupole-time-of-fight mass spectrometry. J. Mass Spectrom. 36(8), 849-865 (2001).
20. Guilhaus M, Selby D, Mlynski V. Orthogonal acceleration time-of-fight mass spectrometry. Mass Spectrom. Rev. 19(2), 65-107 (2000).
21. Belov ME, Clowers BH, Prior DC et al. Dynamically multiplexed ion mobility time-of-fight mass spectrometry. Anal. Chem. 80(15), 5873-5883 (2008).
22. Dillen L, Cools W, Vereyken L et al. Comparison of triple quadrupole and high-resolution TOF-MS for quantifcation of peptides. Bioanalysis 4(5), 565-579 (2012).
23. Makarov A. Electrostatic axially harmonic orbital trapping: a high-performance technique of mass ana lysis. Anal. Chem. 72 (6), 1156-1162 (2000).
24. Hardman M, Makarov AA. Interfacing the orbitrap mass analyzer to an electrospray ion source. Anal. Chem. 75(7), 1699-1705 (2003).
25. Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Graham Cooks R. The Orbitrap: a new mass spectrometer. J. Mass Spectrom. 40(4), 430-443 (2005).
26. Makarov A, Scigelova M. Coupling liquid chromatography to Orbitrap mass spectrometry. J. Chromatogr. A 1217(25), 3938-3945 (2010).
27. Marshall AG, Hendrickson CL, Jackson GS. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom. Rev. 17(1), 1-35 (1998).
28. Scigelova M, Makarov A. Advances in bioanalytical LC-MS using the Orbitrap mass analyzer. Bioanalysis 1(4), 741-754 (2009).
29. Mcalister GC, Berggren WT, Griep-Raming J et al. A proteomics grade electron transfer dissociation-enabled hybrid linear ion trap-orbitrap mass spectrometer. J. Proteome Res. 7(8), 3127-3136 (2008).
30. Michalski A, Damoc E, Lange O et al. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC-MS/MS and versatile peptide fragmentation modes. Mol. Cell Proteomics 11(3), O111013698 (2012).
31. Mann M, Hendrickson RC, Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. 70, 437-473 (2001).
32. Smith RD, Loo JA, Edmonds CG, Barinaga CJ, Udseth HR. New developments in biochemical mass spectrometry: electrospray ionization. Anal. Chem. 62(9), 882-899 (1990).
33. Abzalimov RR, Kaltashov IA. Electrospray ionization mass spectrometry of highly heterogeneous protein systems: protein ion charge state assignment via incomplete charge reduction. Anal. Chem. 82(18), 7523-7526 (2010).
34. Taichrib A, Pelzing M, Pellegrino C, Rossi M, Neususs C. High resolution TOF MS coupled to CE for the ana lysis of isotopically resolved intact proteins. J. Proteomics 74(7), 958-966 (2011).
35. Beck A, Bussat MC, Zorn N et al. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 819(2), 203-218 (2005).
36. Hills AE, Patel A, Boyd P, James DC. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells. Biotechnol. Bioeng. 75(2), 239-251 (2001).
37. Kunkel JP, Jan DC, Butler M, Jamieson JC. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors. Biotechnol. Prog. 16(3), 462-470 (2000).
38. Serrato JA, Palomares LA, Meneses-Acosta A, Ramirez OT. Heterogeneous conditions in dissolved oxygen affect N-glycosylation but not productivity of a monoclonal antibody in hybridoma cultures. Biotechnol. Bioeng. 88(2), 176-188 (2004).
39. Borrebaeck CK, Malmborg AC, Ohlin M. Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics? Immunol. Today 14 (10), 477-479 (1993).
40. Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J. Pharm. Sci. 97(7), 2426-2447 (2008).
41. Zhu L, Van De Lavoir MC, Albanese J et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nat. Biotechnol. 23 (9), 1159-1169 (2005).
42. Leibiger H, Wustner D, Stigler RD, Marx U. Variable domain-linked oligosaccharides of a human monoclonal IgG. structure and infuence on antigen binding. Biochem. J. 338(Pt 2), 529-538 (1999).
43. Jefferis R. Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 21(1), 11-16 (2005).
44. Jiskoot W, Van De Werken G, Martin JM, Green BN, Beuvery EC, Crommelin DJ. Application of electrospray mass spectrometry (ESI-MS) for the ana lysis of monoclonal antibody Fc subunits. Pharm. Res. 9(7), 945-951 (1992).
45. Wang W, Singh S, Zeng DL, King K, Nema S. Antibody structure, instability, and formulation. J. Pharm. Sci. 96(1), 1-26 (2007).
46. Liu H, Gaza-Bulseco G, Lundell E. Assessment of antibody fragmentation by reversed-phase liquid chromatography and mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 876(1), 13-23 (2008).
47. Mclafferty FW. Tandem mass spectrometry. Science 214 (4518), 280-287 (1981).
48. Hirayama K, Takahashi R, Akashi S et al. Primary structure of Paim I, an alpha-amylase inhibitor from Streptomyces corchorushii, determined by the combination of Edman degradation and fast atom bombardment mass spectrometry. Biochemistry 26(20), 6483-6488 (1987).
49. Henzel WJ, Billeci TM, Stults J T, Wong SC, Grimley C, Watanabe C. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc. Natl Acad. Sci. USA 90(11), 5011-5015 (1993).
50. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 422(6928), 198-207 (2003).
51. Bogdanov B, Smith RD. Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom. Rev. 24(2), 168-200 (2005).
52. Chait BT. Chemistry. Mass spectrometry. bottom-up or top-down? Science 314(5796), 65-66 (2006).
53. Smith RD. Trends in mass spectrometry instrumentation for proteomics. Trends Biotechnol. 20(12 Suppl.), S3-S7 (2002).
54. Chen G, Warrack BM, Goodenough AK, Wei H, Wang-Iverson DB, Tymiak AA. Characterization of protein therapeutics by mass spectrometry. recent developments and future directions. Drug Discov. Today 16(1-2), 58-64 (2011).
55. Borchers C, Peter JF, Hall MC, Kunkel TA, Tomer KB. Identifcation of in-gel digested proteins by complementary peptide mass fngerprinting and tandem mass spectrometry data obtained on an electrospray ionization quadrupole time-of-fight mass spectrometer. Anal. Chem. 72 (6), 1163-1168 (2000).
56. Lisacek FC, Traini MD, Sexton D, Harry JL, Wilkins MR. Strategy for protein isoform identifcation from expressed sequence tags and its application to peptide mass fngerprinting. Proteomics 1(2), 186-193 (2001).
57. Wei H, Nolkrantz K, Parkin MC, Chisolm CN, O'callaghan JP, Kennedy RT. Identifcation and quantifcation of neuropeptides in brain tissue by capillary liquid chromatography coupled off-line to MALDI-TOF and MALDI-TOF/TOF-MS. Anal. Chem. 78(13), 4342-4351 (2006).
58. Abraham P, Giannone RJ, Adams RM, Kalluri U, Tuskan GA, Hettich RL. Putting the pieces together: high-performance LC-MS/MS provides network-, pathway-, and protein-level perspectives in populus. Mol. Cell Proteomics 12(1), 106-119 (2013).
59. Kocher T, Pichler P, Swart R, Mechtler K. Analysis of protein mixtures from whole-cell extracts by single-run nanoLC-MS/MS using ultralong gradients. Nat. Protoc. 7(5), 882-890 (2012).
60. Xie H, Gilar M, Gebler JC. Characterization of protein impurities and site-specifc modifcations using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry. Anal. Chem. 81(14), 5699-5708 (2009).
61. Harris RJ, Kabakoff B, Macchi FD et al. Identifcation of multiple sources of charge heterogeneity in a recombinant antibody. J. Chromatogr. B Biomed. Sci. Appl 752(2), 233-245 (2001).
62. Robinson NE, Robinson AB. Prediction of protein deamidation rates from primary and three-dimensional structure. Proc. Natl Acad. Sci. USA 98(8), 4367-4372 (2001).
63. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 262(2), 785-794 (1987).
64. Wright HT. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. Crit. Rev.Biochem. Mol. Biol. 26(1), 1-52 (1991).
65. Cournoyer JJ, Pittman JL, Ivleva VB et al. Deamidation. Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation. Protein Sci. 14(2), 452-463 (2005).
66. O'connor PB, Cournoyer JJ, Pitteri SJ, Chrisman PA, Mcluckey SA. Differentiation of aspartic and isoaspartic acids using electron transfer dissociation. J. Am. Soc. Mass Spectrom. 17(1), 15-19 (2006).
67. Sargaeva NP, Lin C, O'connor PB. Identifcation of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions. Anal. Chem. 81(23), 9778-9786 (2009).
68. Stadtman ER. Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation. Arch. Biochem. Biophys. 423(1), 2-5 (2004).
69. Taggart C, Cervantes-Laurean D, Kim G et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275(35), 27258-27265 (2000).
70. Vogt W. Oxidation of methionyl residues in proteins. tools, targets, and reversal. Free Radic. Biol. Med. 18(1), 93-105 (1995).
71. Shacter E, Williams JA, Hinson RM, Senturker S, Lee YJ. Oxidative stress interferes with cancer chemotherapy. inhibition of lymphoma cell apoptosis and phagocytosis. Blood 96(1), 307-313 (2000).
72. Hovorka S, Schoneich C. Oxidative degradation of pharmaceuticals. theory, mechanisms and inhibition. J. Pharm. Sci. 90(3), 253-269 (2001).
73. Scislowski PW, Foster AR, Fuller MF. Regulation of oxidative degradation of L-lysine in rat liver mitochondria. Biochem. J. 300 (Pt 3), 887-891 (1994).
74. Liu H, Gaza-Bulseco G, Zhou L. Mass spectrometry ana lysis of photo-induced methionine oxidation of a recombinant human monoclonal antibody. J. Am. Soc. Mass Spectrom. 20(3), 525-528 (2009).
75. Houde D, Kauppinen P, Mhatre R, Lyubarskaya Y. Determination of protein oxidation by mass spectrometry and method transfer to quality control. J. Chromatogr. A 1123(2), 189-198 (2006).
76. Lin HJ, Lin CH, Tseng HC, Chen YH. Detecting disulfde crosslinks of high-molecular weight complexes in mouse SVS proteins by diagonal electrophoresis. Anal. Biochem. 352(2), 296-298 (2006).
77. Gorman JJ, Wallis TP, Pitt JJ. Protein disulfde bond determination by mass spectrometry. Mass Spectrom. Rev. 21(3), 183-216 (2002).
78. Wu J, Watson JT. A novel methodology for assignment of disulfde bond pairings in proteins. Protein Sci. 6(2), 391-398 (1997).
79. Wu SL, Jiang H, Lu Q, Dai S, Hancock WS, Karger BL. Mass spectrometric determination of disulfde linkages in recombinant therapeutic proteins using online LC-MS with electron-transfer dissociation. Anal. Chem. 81(1), 112-122 (2009).
80. Thomsen MK, Hansen BS, Nilsson P et al. Pharmacological characterization of a biosynthetic trisulfde-containing hydrophobic derivative of human growth hormone. comparison with standard 22 K growth hormone. Pharmacol. Toxicol. 74 (6), 351-358 (1994).
81. Gu S, Wen D, Weinreb PH et al. Characterization of trisulfde modifcation in antibodies. Anal. Biochem. 400(1), 89-98 (2010).
82. Nielsen RW, Tachibana C, Hansen NE, Winther JR. Trisulfdes in proteins. Antioxidants Redox Signaling 15(1), 67-75 (2011).
83. Lim A, Prokaeva T, Mccomb ME et al. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis. Anal. Chem. 74 (4), 741-751 (2002).
84. Fu J, Bongers J, Tao L et al. Characterization and identifcation of alanine to serine sequence variants in an IgG4 monoclonal antibody produced in mammalian cell lines. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 908, 1-8 (2012).
85. Williamson BL, Marchese J, Morrice NA. Automated identifcation and quantifcation of protein phosphorylation sites by LC/MS on a hybrid triple quadrupole linear ion trap mass spectrometer. Mol. Cell Proteomics 5(2), 337-346 (2006).
86. Gadgil HS, Bondarenko PV, Pipes G et al. The LC-MS ana lysis of glycation of IgG molecules in sucrose containing formulations. J. Pharm. Sci. 96(10), 2607-2621 (2007).
87. Jensen ON. Modifcation-specifc proteomics. characterization of post-translational modifcations by mass spectrometry. Curr. Opin. Chem. Biol. 8(1), 33-41 (2004).
88. Salzano AM, Crescenzi M. Mass spectrometry for protein identifcation and the study of post translational modifcations. Annali dell'Istituto superiore di sanita 41(4), 443-450 (2005).
89. Kellie JF, Tran JC, Lee JE et al. The emerging process of top down mass spectrometry for protein ana lysis. biomarkers, protein-therapeutics, and achieving high throughput. Mol. Biosyst. 6 (9), 1532-1539 (2010).
90. Han X, Jin M, Breuker K, McLafferty FW. Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons. Science 314(5796), 109-112 (2006).
91. Armirotti A, Benatti U, Damonte G. Top-down proteomics with a quadrupole time-of-fight mass spectrometer and collision-induced dissociation. Rapid Commun. Mass Spectrom. 23(5), 661-666 (2009).
92. Hanisch FG. O-glycoproteomics. site-specifc O-glycoprotein ana lysis by CID/ETD electrospray ionization tandem mass spectrometry and top-down glycoprotein sequencing by in-source decay MALDI mass spectrometry. Methods Mol. Biol. 842, 179-189 (2012).
93. Zhang Y, Sinaiko AR, Nelsestuen GL. Glycoproteins and glycosylation. apolipoprotein c3 glycoforms by top-down maldi-tof mass spectrometry. Methods Mol. Biol. 909, 141-150 (2012).
94. Yoo C, Suckau D, Sauerland V, Ronk M, Ma M. Toward top-down determination of PEGylation site using MALDI in-source decay MS ana lysis. J. Am. Soc. Mass Spectrom. 20(2), 326-333 (2009).
95. Liu Z, Schey KL. Fragmentation of multiply-charged intact protein ions using MALDI TOF-TOF mass spectrometry. J. Am. Soc. Mass Spectrom. 19(2), 231-238 (2008).
96. Fagerquist CK, Sultan O. Top-down proteomic identifcation of furin-cleaved alpha-subunit of Shiga toxin 2 from Escherichia coli O157:H7 using MALDI-TOF-TOF-MS/MS. J. Biomed. Biotechnol. 2010, 123460 (2010).
97. Maltman DJ, Brand S, Belau E, Paape R, Suckau D, Przyborski SA. Top-down label-free LC-MALDI ana lysis of the peptidome during neural progenitor cell differentiation reveals complexity in cytoskeletal protein dynamics and identifes progenitor cell markers. Proteomics 11(20), 3992-4006 (2011).
98. Macek B, Waanders LF, Olsen JV, Mann M. Top-down protein sequencing and MS3 on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer. Mol. Cell Proteomics 5(5), 949-958 (2006).
99. Fornelli L, Damoc E, Thomas PM et al. Analysis of intact monoclonal antibody IgG1 by electron transfer dissociation Orbitrap FTMS. Mol. Cell Proteomics 11(12), 1758-1767 (2012).
100. Bondarenko PV, Second TP, Zabrouskov V, Makarov AA, Zhang Z. Mass measurement and top-down HPLC-MS ana lysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20 (8), 1415-1424 (2009).
101. Zhang Z, Shah B. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry. Anal. Chem. 79(15), 5723-5729 (2007).
102. Cannon J, Lohnes K, Wynne C, Wang Y, Edwards N, Fenselau C. High-throughput middle-down ana lysis using an orbitrap. J. Proteome Res. 9(8), 3886-3890 (2010).
103. Pipes GD, Campbell P, Bondarenko PV, Kerwin BA, Treuheit MJ, Gadgil HS. Middle-down fragmentation for the identifcation and quantitation of site-specifc methionine oxidation in an IgG1 molecule. J. Pharm. Sci. 99(11), 4469-4476 (2010).
104. Wu C, Tran JC, Zamdborg L et al. A protease for 'middle-down' proteomics. Nat. Methods 9(8), 822-824 (2012).
105. Xu P, Peng J. Characterization of polyubiquitin chain structure by middle-down mass spectrometry. Anal. Chem. 80(9), 3438-3444 (2008).
106. Shcherbakova I, Mitra S. Hydroxyl-radical footprinting to probe equilibrium changes in RNA tertiary structure. Methods Enzymol. 468, 31-46 (2009).
107. Dong A, Matsuura J, Allison SD, Chrisman E, Manning MC, Carpenter JF. Infrared and circular dichroism spectroscopic characterization of structural differences between beta-lactoglobulin A and B. Biochemistry 35 (5), 1450-1457 (1996).
108. Martin SR, Schilstra MJ. Circular dichroism and its application to the study of biomolecules. Methods Cell Biol. 84, 263-293 (2008).
109. Nguyen LT, Wiencek JM, Kirsch LE. Characterization methods for the physical stability of biopharmaceuticals. PDA J. Pharm. Sci. Technol. 57(6), 429-445 (2003).
110. Swint-Kruse L, Robertson AD. Temperature and pH dependences of hydrogen exchange and global stability for ovomucoid third domain. Biochemistry 35(1), 171-180 (1996).
111. Den Engelsman J, Garidel P, Smulders R et al. Strategies for the assessment of protein aggregates in pharmaceutical biotech product development. Pharm. Res. 28(4), 920-933 (2011).
112. Kaltashov IA, Bobst CE, Abzalimov RR, Berkowitz SA, Houde D. Conformation and dynamics of biopharmaceuticals. transition of mass spectrometry-based tools from academe to industry. J. Am. Soc. Mass Spectrom. 21(3), 323-337 (2010).
113. Hvidt A, Linderstrom-Lang K. Exchange of hydrogen atoms in insulin with deuterium atoms in aqueous solutions. Biochim. Biophys. Acta 14(4), 574-575 (1954).
114. Hvidt A, Linderstrom-Lang K. The kinetics of the deuterium exchange of insulin with D2O; an amendment. Biochim. Biophys. Acta 16(1), 168-169 (1955).
115. Katta V, Chait BT. Conformational changes in proteins probed by hydrogen-exchange electrospray-ionization mass spectrometry. Rapid Commun. Mass Spectrom. 5(4), 214-217 (1991).
116. Zhang Z, Smith DL. Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 2(4), 522-531 (1993).
117. Deng Y, Zhang Z, Smith DL. Comparison of continuous and pulsed labeling amide hydrogen exchange/mass spectrometry for studies of protein dynamics. J. Am. Soc. Mass Spectrom. 10(8), 675-684 (1999).
118. Konermann L, Simmons DA. Protein-folding kinetics and mechanisms studied by pulse-labeling and mass spectrometry. Mass Spectrom. Rev. 22(1), 1-26 (2003).
119. Hossain BM, Konermann L. Pulsed hydrogen/deuterium exchange MS/MS for studying the relationship between noncovalent protein complexes in solution and in the gas phase after electrospray ionization. Anal. Chem. 78 (5), 1613-1619 (2006).
120. Wei H, Ahn J, Yu YQ, Tymiak A, Engen JR, Chen G. Using hydrogen/deuterium exchange mass spectrometry to study conformational changes in granulocyte colony stimulating factor upon PEGylation. J. Am. Soc. Mass Spectrom. 23(3), 498-504 (2012).
121. Rand KD, Adams CM, Zubarev RA, Jorgensen TJ. Electron capture dissociation proceeds with a low degree of intramolecular migration of peptide amide hydrogens. J. Am. Chem. Soc. 130(4), 1341-1349 (2008).
122. Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence ana lysis by electron transfer dissociation mass spectrometry. Proc. Natl Acad. Sci. USA 101(26), 9528-9533 (2004).
123. Zehl M, Rand KD, Jensen ON, Jorgensen TJ. Electron transfer dissociation facilitates the measurement of deuterium incorporation into selectively labeled peptides with single residue resolution. J. Am. Chem. Soc. 130 (51), 17453-17459 (2008).
124. Zubarev RA. Reactions of polypeptide ions with electrons in the gas phase. Mass Spectrom. Rev. 22(1), 57-77 (2003).
125. Landgraf RR, Chalmers MJ, Griffn PR. Automated hydrogen/deuterium exchange electron transfer dissociation high resolution mass spectrometry measured at single-amide resolution. J. Am. Soc. Mass Spectrom. 23(2), 301-309 (2012).
126. Rand KD, Zehl M, Jensen ON, Jorgensen TJ. Protein hydrogen exchange measured at single-residue resolution by electron transfer dissociation mass spectrometry. Anal. Chem. 81(14), 5577-5584 (2009).
127. Lanman J, Lam TT, Barnes S et al. Identifcation of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. J. Mol. Biol. 325(4), 759-772 (2003).
128. Pan J, Rintala-Dempsey AC, Li Y, Shaw GS, Konermann L. Folding kinetics of the S100A11 protein dimer studied by time-resolved electrospray mass spectrometry and pulsed hydrogen-deuterium exchange. Biochemistry 45(9), 3005-3013 (2006).
129. Wales TE, Engen JR. Hydrogen exchange mass spectrometry for the ana lysis of protein dynamics. Mass Spectrom. Rev. 25(1), 158-170 (2006).
130. 2+-induced conformational changes in porcine calmodulin by H/D exchange and ESI-MS. effect of cations and ionic strength. Biochemistry 42 (51), 15388-15397 (2003).
131. Houde D, Arndt J, Domeier W, Berkowitz S, Engen JR. Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry. Anal. Chem. 81(7), 2644-2651 (2009).
132. Del Mar C, Greenbaum EA, Mayne L, Englander SW, Woods VL, Jr. Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level. Proc. Natl Acad. Sci. USA 102 (43), 15477-15482 (2005).
133. Tobler SA, Fernandez EJ. Structural features of interferon-gamma aggregation revealed by hydrogen exchange. Protein Sci. 11(6), 1340-1352 (2002).
134. Bobst CE, Thomas JJ, Salinas PA, Savickas P, Kaltashov IA. Impact of oxidation on protein therapeutics. conformational dynamics of intact and oxidized acid-beta-glucocerebrosidase at near-physiological pH. Protein Sci. 19(12), 2366-2378 (2010).
135. Bobst CE, Abzalimov RR, Houde D et al. Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches. Anal. Chem. 80 (19), 7473-7481 (2008).
136. Houde D, Berkowitz SA, Engen JR. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. J. Pharm. Sci. 100 (6), 2071-2086 (2011).
137. Bissantz C, Kuhn B, Stahl M. A medicinal chemist's guide to molecular interactions. J. Med. Chem. 53(14), 5061-5084 (2010).
138. Coales SJ, Tuske SJ, Tomasso JC, Hamuro Y. Epitope mapping by amide hydrogen/deuterium exchange coupled with immobilization of antibody, on-line proteolysis, liquid chromatography and mass spectrometry. Rapid Commun. Mass Spectrom. 23(5), 639-647 (2009).
139. Keppel TR, Howard BA, Weis DD. Mapping unstructured regions and synergistic folding in intrinsically disordered proteins with amide H/D exchange mass spectrometry. Biochemistry 50(40), 8722-8732 (2011).
140. Yamada N, Suzuki E, Hirayama K. Identifcation of the interface of a large protein-protein complex using H/D exchange and Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun. Mass Spectrom. 16(4), 293-299 (2002).
141. Zhang Q, Willison LN, Tripathi P et al. Epitope mapping of a 95 kDa antigen in complex with antibody by solution-phase amide backbone hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 83(18), 7129-7136 (2011).
142. Zhou B, Zhang ZY. Application of hydrogen/deuterium exchange mass spectrometry to study protein tyrosine phosphatase dynamics, ligand binding, and substrate specifcity. Methods 42(3), 227-233 (2007).
143. Maleknia SD, Brenowitz M, Chance MR. Millisecond radiolytic modifcation of peptides by synchrotron X-rays identifed by mass spectrometry. Anal. Chem. 71(18), 3965-3973 (1999).
144. Maleknia SD, Kiselar JG, Downard KM. Hydroxyl radical probe of the surface of lysozyme by synchrotron radiolysis and mass spectrometry. Rapid Commun. Mass Spectrom. 16(1), 53-61 (2002).
145. Maleknia SD, Downard K. Radical approaches to probe protein structure, folding, and interactions by mass spectrometry. Mass Spectrom. Rev. 20(6), 388-401 (2001).
146. Takamoto K, Chance MR. Radiolytic protein footprinting with mass spectrometry to probe the structure of macromolecular complexes. Annu Rev Biophys. Biomol. Struct. 35, 251-276 (2006).
147. Pan Y, Brown L, Konermann L. Mapping the structure of an integral membrane protein under semi-denaturing conditions by laser-induced oxidative labeling and mass spectrometry. J. Mol. Biol. 394(5), 968-981 (2009).
148. Pan Y, Stocks BB, Brown L, Konermann L. Structural characterization of an integral membrane protein in its natural lipid environment by oxidative methionine labeling and mass spectrometry. Anal. Chem. 81(1), 28-35 (2009).
149. Watson C, Sharp JS. Conformational ana lysis of therapeutic proteins by hydroxyl radical protein footprinting. AAPS J. 14(2), 206-217 (2012).
150. Sharp JS, Becker JM, Hettich RL. Protein surface mapping by chemical oxidation. structural ana lysis by mass spectrometry. Anal. Biochem. 313(2), 216-225 (2003).
151. Cheal SM, Ng M, Barrios B, Miao Z, Kalani AK, Meares CF. Mapping protein-protein interactions by localized oxidation. consequences of the reach of hydroxyl radical. Biochemistry 48 (21), 4577-4586 (2009).
152. Xu G, Chance MR. Radiolytic modifcation of sulfur-containing amino acid residues in model peptides. fundamental studies for protein footprinting. Anal. Chem. 77(8), 2437-2449 (2005).
153. Maleknia SD, Chance MR, Downard KM. Electrospray-assisted modifcation of proteins: a radical probe of protein structure. Rapid Commun. Mass Spectrom. 13(23), 2352-2358 (1999).
154. Wong JW, Maleknia SD, Downard KM. Study of the ribonuclease-S-protein- peptide complex using a radical probe and electrospray ionization mass spectrometry. Anal. Chem. 75 (7), 1557-1563 (2003).
155. Sharp JS, Becker JM, Hettich RL. Analysis of protein solvent accessible surfaces by photochemical oxidation and mass spectrometry. Anal. Chem. 76(3), 672-683 (2004).
156. Sharp JS, Guo JT, Uchiki T, Xu Y, Dealwis C, Hettich RL. Photochemical surface mapping of C14S-Sml1p for constrained computational modeling of protein structure. Anal. Biochem. 340(2), 201-212 (2005).
157. Hambly DM, Gross ML. Laser fash photolysis of hydrogen peroxide to oxidize protein solvent-accessible residues on the microsecond timescale. J. Am. Soc. Mass Spectrom. 16(12), 2057-2063 (2005).
158. Aye TT, Low TY, Sze SK. Nanosecond laser-induced photochemical oxidation method for protein surface mapping with mass spectrom-etry. Anal. Chem. 77(18), 5814-5822 (2005).
159. Jones LM, J BS, J AC, Gross ML. Fast photochemical oxidation of proteins for epitope mapping. Anal. Chem. 83(20), 7657-7661 (2011).
160. Gau BC, Sharp JS, Rempel DL, Gross ML. Fast photochemical oxidation of protein footprints faster than protein unfolding. Anal. Chem. 81(16), 6563-6571 (2009).
161. Chen J, Rempel DL, Gross ML. Temperature jump and fast photochemical oxidation probe submillisecond protein folding. J. Am. Chem. Soc. 132(44), 15502-15504 (2010).
162. Zhang H, Gau BC, Jones LM, Vidavsky I, Gross ML. Fast photochemical oxidation of proteins for comparing structures of protein-ligand complexes: the calmodulin-peptide model system. Anal. Chem. 83(1), 311-318 (2011).